SUN PHARMACEUTICAL INDUSTRIES

Stock gained 1.7% to close at Rs 681.15

The company said its subsidiary Caraco has received US FDA clearance to resume operations at its manufacturing facility and packaging sites in Detriot and Wixom, Michigan

"During their inspection, the USFDA reviewed the certification reports for production of Carvedilol USP as well as Paramomycin USP, and subsequently reviewed corrective actions on 483's. Currently, Caraco may resume products of only these two products," according to a release